PlainRecalls
FDA Drug Low Class III Terminated

Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA

Reported: June 5, 2013 Initiated: March 18, 2013 #D-499-2013

Product Description

Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA

Reason for Recall

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

Details

Units Affected
6 cards of 28 tablets
Distribution
MO
Location
Tulsa, OK

Frequently Asked Questions

What product was recalled?
Camila 0.35 mg Tablets, 6 cards of 28 pills, Dist. By: Physicians Total Care, Tulsa, OK --- NDC 54868-4814-0, MFG By TEVA Pharmaceuticals USA, Sellersville, PA. Recalled by Physicians Total Care, Inc.. Units affected: 6 cards of 28 tablets.
Why was this product recalled?
Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing
Which agency issued this recall?
This recall was issued by the FDA Drug on June 5, 2013. Severity: Low. Recall number: D-499-2013.